efeitos da atorvastatina e do polimorfismo t-786c do gene enos sobre parâmetros do metabolismo lipídico plasmático effects of atorvastatin and t-786c polymorphism of enos gene on plasma metabolic lipid parameters
Метрики качества и эффективности статьи
Readership in this journal
EmergingRanked #1 of 230 articles by views in revista cubana de ciencias informáticas
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 230 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Аннотация
BACKGROUND: Endothelial nitric oxide synthase (eNOS) activity may be modulated by high-density lipoprotein cholesterol (HDL-C), statins or polymorphisms, such as the T-786C of eNOS. OBJECTIVE: This study aimed at evaluating if the T-786C polymorphism is associated with changes of atorvastatin effects on the lipid profile, on the concentrations of metabolites of nitric oxide (NO) and of high sensitivity C-reactive protein (hsCRP). METHODS: Thirty male volunteers, asymptomatic, aged between 18 and 56 years were genotyped and classified according to absence (TT, n = 15) or presence (CC, n = 15) of the polymorphism. They were randomly selected for the use of placebo or atorvastatin (10 mg/day/14 days). After each treatment lipids, lipoproteins, HDL2 and HDL3 composition, cholesteryl ester transfer protein (CETP) activity, metabolites of NO and hsCRP were evaluated. RESULTS: The comparisons between genotypes after placebo showed an increase in CETP activity in a polymorphism-dependent way (TT, 12±7; CC, 22±12; p < 0.05). The interaction analyses between treatments indicated that atorvastatin has an effect on cholesterol, LDL, nitrite and lipid-protein ratios (HDL2 and HDL3) (p < 0.001) in both genotypes. Interestingly, we observed genotype/drug interactions on CETP (p < 0.07) and lipoprotein (a) (Lp(a)) (p < 0.056), leading to a borderline decrease in CETP, but with no effect on Lp(a). HsCRP showed no alteration. CONCLUSION: These results suggest that statin treatment may be relevant for primary prevention of atherosclerosis in patients with the T-786C polymorphism of eNOS, considering the effects on lipid metabolism.
| Ссылочный ключ |
zago2013arquivosefeitos
Используйте этот ключ для автоцитирования в рукописи при использовании
SciMatic Manuscript Manager или Thesis Manager
|
|---|---|
| Авторы | |
| Журнал | revista cubana de ciencias informáticas |
| Год | 2013 |
| DOI |
DOI не найден
|
| URL | |
| Ключевые слова |
Цитирования
Цитирования не найдены. Чтобы добавить цитирование, свяжитесь с администратором по адресу info@scimatic.org
ZincirX productsfrom the team behind Journament
-
PatentYazar
Patent drafts for the EPO, USPTO and TürkPatent
From inventor notes to a DOCX draft: description, claims, abstract. The machine drafts, the attorney signs.
See how it works (opens in a new tab) -
Projenator
Have a project idea? Score and plan it with AI
AI scores your idea in five dimensions and builds a phased plan. Your first project is free, no card needed.
Start your first project (opens in a new tab)
Файлы cookie
Мы используем строго необходимые файлы cookie, чтобы сайт работал и вы оставались в системе. С вашего разрешения мы также будем использовать Google Analytics, чтобы видеть, как используется сайт, и Google AdSense, чтобы показывать рекламу на страницах журналов и статей. Оба инструмента выключены, пока вы их не примете, и вы можете изменить решение в любой момент. Как мы используем cookie · Уведомление KVKK (Турция)
Настройки cookie
Комментарии
Комментариев пока нет. Будьте первым, кто прокомментирует эту статью.